Here is what the page “FDA Removes Black-Box Warnings from Three Menopause Estrogen Patches, Bypassing Advisers A” contains. The US Food and Drug Administration (FDA) announced on Friday that three additional estrogen patches for menopause will no longer carry black-box warnings about cardiovascular disease, breast cancer, and dementia. This action follows the removal of similar warnings from six menopause treatments in F This action follows the removal of similar warnings from six menopause treatments in February, bringing the total to nine products affected.
The agency did not convene an advisory committee, and officials offered limited scientific justification during the press briefing, prompting concern among experts about a lack of transparency. The decision comes amid ongoing shortages of menopause patches across the United States, which may have influenced the regulatory move. Black-box warnings are the FDA's strongest safety alert, and their removal could alter prescribing practices and patient perceptions of risk. The full version stays on the original page, which this listing opens directly.